Direct angiotensin II type 2 receptor stimulation ameliorates insulin resistance in type 2 diabetes mice with PPARγ activation.

<h4>Objectives</h4>The role of angiotensin II type 2 (AT(2)) receptor stimulation in the pathogenesis of insulin resistance is still unclear. Therefore we examined the possibility that direct AT(2) receptor stimulation by compound 21 (C21) might contribute to possible insulin-sensitizing...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kousei Ohshima, Masaki Mogi, Fei Jing, Jun Iwanami, Kana Tsukuda, Li-Juan Min, Akiyoshi Ogimoto, Björn Dahlöf, Ulrike M Steckelings, Tomas Unger, Jitsuo Higaki, Masatsugu Horiuchi
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/2b1a49c707ed426aad42ef0986ee2c79
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2b1a49c707ed426aad42ef0986ee2c79
record_format dspace
spelling oai:doaj.org-article:2b1a49c707ed426aad42ef0986ee2c792021-11-18T08:08:56ZDirect angiotensin II type 2 receptor stimulation ameliorates insulin resistance in type 2 diabetes mice with PPARγ activation.1932-620310.1371/journal.pone.0048387https://doaj.org/article/2b1a49c707ed426aad42ef0986ee2c792012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23155382/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Objectives</h4>The role of angiotensin II type 2 (AT(2)) receptor stimulation in the pathogenesis of insulin resistance is still unclear. Therefore we examined the possibility that direct AT(2) receptor stimulation by compound 21 (C21) might contribute to possible insulin-sensitizing/anti-diabetic effects in type 2 diabetes (T2DM) with PPARγ activation, mainly focusing on adipose tissue.<h4>Methods</h4>T2DM mice, KK-Ay, were subjected to intraperitoneal injection of C21 and/or a PPARγ antagonist, GW9662 in drinking water for 2 weeks. Insulin resistance was evaluated by oral glucose tolerance test, insulin tolerance test, and uptake of 2-[(3)H] deoxy-D-glucose in white adipose tissue. Morphological changes of adipose tissues as well as adipocyte differentiation and inflammatory response were examined.<h4>Results</h4>Treatment with C21 ameliorated insulin resistance in KK-Ay mice without influencing blood pressure, at least partially through effects on the PPARγ pathway. C21 treatment increased serum adiponectin concentration and decreased TNF-α concentration; however, these effects were attenuated by PPARγ blockade by co-treatment with GW9662. Moreover, we observed that administration of C21 enhanced adipocyte differentiation and PPARγ DNA-binding activity, with a decrease in inflammation in white adipose tissue, whereas these effects of C21 were attenuated by co-treatment with GW9662. We also observed that administration of C21 restored β cell damage in diabetic pancreatic tissue.<h4>Conclusion</h4>The present study demonstrated that direct AT(2) receptor stimulation by C21 accompanied with PPARγ activation ameliorated insulin resistance in T2DM mice, at least partially due to improvement of adipocyte dysfunction and protection of pancreatic β cells.Kousei OhshimaMasaki MogiFei JingJun IwanamiKana TsukudaLi-Juan MinAkiyoshi OgimotoBjörn DahlöfUlrike M SteckelingsTomas UngerJitsuo HigakiMasatsugu HoriuchiPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 11, p e48387 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Kousei Ohshima
Masaki Mogi
Fei Jing
Jun Iwanami
Kana Tsukuda
Li-Juan Min
Akiyoshi Ogimoto
Björn Dahlöf
Ulrike M Steckelings
Tomas Unger
Jitsuo Higaki
Masatsugu Horiuchi
Direct angiotensin II type 2 receptor stimulation ameliorates insulin resistance in type 2 diabetes mice with PPARγ activation.
description <h4>Objectives</h4>The role of angiotensin II type 2 (AT(2)) receptor stimulation in the pathogenesis of insulin resistance is still unclear. Therefore we examined the possibility that direct AT(2) receptor stimulation by compound 21 (C21) might contribute to possible insulin-sensitizing/anti-diabetic effects in type 2 diabetes (T2DM) with PPARγ activation, mainly focusing on adipose tissue.<h4>Methods</h4>T2DM mice, KK-Ay, were subjected to intraperitoneal injection of C21 and/or a PPARγ antagonist, GW9662 in drinking water for 2 weeks. Insulin resistance was evaluated by oral glucose tolerance test, insulin tolerance test, and uptake of 2-[(3)H] deoxy-D-glucose in white adipose tissue. Morphological changes of adipose tissues as well as adipocyte differentiation and inflammatory response were examined.<h4>Results</h4>Treatment with C21 ameliorated insulin resistance in KK-Ay mice without influencing blood pressure, at least partially through effects on the PPARγ pathway. C21 treatment increased serum adiponectin concentration and decreased TNF-α concentration; however, these effects were attenuated by PPARγ blockade by co-treatment with GW9662. Moreover, we observed that administration of C21 enhanced adipocyte differentiation and PPARγ DNA-binding activity, with a decrease in inflammation in white adipose tissue, whereas these effects of C21 were attenuated by co-treatment with GW9662. We also observed that administration of C21 restored β cell damage in diabetic pancreatic tissue.<h4>Conclusion</h4>The present study demonstrated that direct AT(2) receptor stimulation by C21 accompanied with PPARγ activation ameliorated insulin resistance in T2DM mice, at least partially due to improvement of adipocyte dysfunction and protection of pancreatic β cells.
format article
author Kousei Ohshima
Masaki Mogi
Fei Jing
Jun Iwanami
Kana Tsukuda
Li-Juan Min
Akiyoshi Ogimoto
Björn Dahlöf
Ulrike M Steckelings
Tomas Unger
Jitsuo Higaki
Masatsugu Horiuchi
author_facet Kousei Ohshima
Masaki Mogi
Fei Jing
Jun Iwanami
Kana Tsukuda
Li-Juan Min
Akiyoshi Ogimoto
Björn Dahlöf
Ulrike M Steckelings
Tomas Unger
Jitsuo Higaki
Masatsugu Horiuchi
author_sort Kousei Ohshima
title Direct angiotensin II type 2 receptor stimulation ameliorates insulin resistance in type 2 diabetes mice with PPARγ activation.
title_short Direct angiotensin II type 2 receptor stimulation ameliorates insulin resistance in type 2 diabetes mice with PPARγ activation.
title_full Direct angiotensin II type 2 receptor stimulation ameliorates insulin resistance in type 2 diabetes mice with PPARγ activation.
title_fullStr Direct angiotensin II type 2 receptor stimulation ameliorates insulin resistance in type 2 diabetes mice with PPARγ activation.
title_full_unstemmed Direct angiotensin II type 2 receptor stimulation ameliorates insulin resistance in type 2 diabetes mice with PPARγ activation.
title_sort direct angiotensin ii type 2 receptor stimulation ameliorates insulin resistance in type 2 diabetes mice with pparγ activation.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/2b1a49c707ed426aad42ef0986ee2c79
work_keys_str_mv AT kouseiohshima directangiotensiniitype2receptorstimulationamelioratesinsulinresistanceintype2diabetesmicewithppargactivation
AT masakimogi directangiotensiniitype2receptorstimulationamelioratesinsulinresistanceintype2diabetesmicewithppargactivation
AT feijing directangiotensiniitype2receptorstimulationamelioratesinsulinresistanceintype2diabetesmicewithppargactivation
AT juniwanami directangiotensiniitype2receptorstimulationamelioratesinsulinresistanceintype2diabetesmicewithppargactivation
AT kanatsukuda directangiotensiniitype2receptorstimulationamelioratesinsulinresistanceintype2diabetesmicewithppargactivation
AT lijuanmin directangiotensiniitype2receptorstimulationamelioratesinsulinresistanceintype2diabetesmicewithppargactivation
AT akiyoshiogimoto directangiotensiniitype2receptorstimulationamelioratesinsulinresistanceintype2diabetesmicewithppargactivation
AT bjorndahlof directangiotensiniitype2receptorstimulationamelioratesinsulinresistanceintype2diabetesmicewithppargactivation
AT ulrikemsteckelings directangiotensiniitype2receptorstimulationamelioratesinsulinresistanceintype2diabetesmicewithppargactivation
AT tomasunger directangiotensiniitype2receptorstimulationamelioratesinsulinresistanceintype2diabetesmicewithppargactivation
AT jitsuohigaki directangiotensiniitype2receptorstimulationamelioratesinsulinresistanceintype2diabetesmicewithppargactivation
AT masatsuguhoriuchi directangiotensiniitype2receptorstimulationamelioratesinsulinresistanceintype2diabetesmicewithppargactivation
_version_ 1718422158020968448